Advisory Committee

Our external advisory committee is a group of senior policy makers, consultants, lawyers, and physicians who provide strategic advice to the Centre from an outside perspective.


David Sweanor (Chair)

Adjunct Professor
University of Ottawa Faculty of Law
David's primary policy involvement has been in spearheading the development of efforts to reduce cigarette smoking in Canada and globally. This has been done as legal counsel to health activist groups, an advisor to a wide range of entities and in numerous publications, media interviews and speeches. He has worked with such bodies as the World Health Organization, World Bank, Pan American Health Organization, International Union Against Cancer and numerous governments, foundations, law firms and non-governmental organizations. His efforts have encompassed taxation policy, advertising restrictions, package warnings, protection from environmental tobacco smoke, smoking cessation interventions, litigation, product regulation and harm reduction initiatives.
He has testified before parliamentary committees federally and provincially in Canada as well as in other countries, and before both Senate and House committees in the United States of America. He has also received various awards for his work, including a ‘Public Health Hero’ lifetime achievement award from the Pan-American Health Organization.
David lives in Ottawa, and engages in extensive volunteer and philanthropic work that is focused on an eclectic range of issues. But they are still dominated by an interest in public policy interventions that increase the length and quality of life.


Daniel Boivin

Gowling WLG
A partner in Gowling WLG's Ottawa office, Daniel is a key member of the firm's Advocacy Group. His practice focuses on health law and medical defence, including acting as counsel to the Canadian Medical Protective Association and the physicians. He also provides advice in matters of commercial litigation and constitutional linguistic issues.
Daniel has appeared before the Ontario Superior Court of Justice, the Ontario Court of Appeal, the Federal Court and the Supreme Court of Canada. Daniel is a part-time professor, teaching evidence law and trial advocacy at the University of Ottawa Faculty of Law. He also lectures on evidence law, advocacy skills and health law with various organizations.


Patricia Kosseim

Senior General Counsel and Director General
Legal Services, Policy, Research and Technology Analysis Branch
Office of the Privacy Commissioner of Canada (OPC)
Patricia provides strategic legal and policy advice on a broad range of privacy issues, oversees privacy research and analysis of emerging information technologies, and represents the Privacy Commissioner before courts and Parliamentary Committees.
Patricia has also worked at Genome Canada and the Canadian Institutes of Health Research where she developed and led national strategies to address ethical, legal and social implications of science and technology.
Prior to moving to Ottawa, Patricia practiced as a lawyer in Montreal for over six years with a large national law firm.
Patricia is currently a member of the Board of Governors of The Ottawa Hospital, the Board of Directors of the Ottawa Hospital Research Institute, the National DNA Databank Advisory Committee, and the Research Integrity Committee of the Fonds de recherche du Québec.


Peter Liu

Chief Scientific Officer and Vice President of Research
Ottawa Heart Institute
Dr. Liu joined the Ottawa Heart Institute as Scientific Director in 2012. Formerly, as the inaugural Director of the Heart & Stroke/Richard Lewar Centre of Excellence at the University of Toronto, Dr. Liu successfully fostered collaboration amongst researchers from various institutions, while increasing the impact of publications. Subsequently as Scientific Director of the Institute of Circulatory and Respiratory Health at the Canadian Institutes of Health Research (CIHR), Dr. Liu launched national networks in imaging, clinical trials and knowledge translation and fostered national and international research networks.
Well known for his contributions to heart failure and cardiac inflammation research, Dr. Liu discovered how viruses can enter the myocardium and trigger inflammation, and how innate and acquired immunity contribute to cardiac remodeling and heart failure progression following injury. His laboratory currently focuses on innovative proteomic biomarkers to detect early and personalize treatment for cardiac diseases, and elucidate novel mechanisms of disease.
Dr. Liu has been recognized with numerous awards, including both the Research Achievement Award and the Life Time Achievement Award of the Canadian Cardiovascular Society, the Rick Gallop Award of the Heart & Stroke Foundation, and the Institute of Circulatory & Respiratory Health Distinguished Lecture Award of CIHR, and the Margolese Award from UBC, amongst others.

Kwame McKenzie

Director of Health Equity
Centre for Addiction and Mental Health (CAMH)
Dr. McKenzie is Director of Health Equity at CAMH. He is a full Professor and the Co-Director of the Division of Equity Gender and Population in the Department of Psychiatry at the University of Toronto.  Dr. McKenzie is also CEO of the Wellesley Institute and a member of the Mental Health and Addictions Advisory Council to the Minister of Health. He sits on the Board of the United Way Toronto and the Ontario Hospitals Association.
Dr. McKenzie is an international expert on the social causes of mental illness, suicide and the development of effective, equitable health systems. As a physician, psychiatrist, researcher and policy advisor, Dr. McKenzie has worked to identify the causes of mental illness, particularly in cross-cultural health, for over two decades. He is an active, funded researcher of social, community, clinical and policy issues, and has nearly 200 academic publications, including four books.
Dr. McKenzie has set up award-winning services. In addition to developing health policy for governments, he continues to see patients and train clinicians and researchers. Dr. McKenzie has international experience in Africa, Europe, the Caribbean and United States.

Maureen McTeer

Adjunct Professor
University of Ottawa Faculty of Law
Maureen McTeer is a distinguished Canadian lawyer and author who is currently an adjunct professor of law at the University of Ottawa and a member of the Global Commission on Pollution, Health and Development. For four decades, Ms. McTeer has been a leading advocate for, and symbol of, gender equality in Canada, and has been an influential role model for other women in Canada and abroad. Her interests and engagement span a wide range of challenging social, legal and ethical issues, and her goal is to bring citizens into the discussion and debate on all the major issues that will shape our future. Ms. McTeer has received several honours including: The Governor General’s Award in Commemoration of the Persons case; the Queen’s Gold and Diamond Jubilee Medals; honorary degrees from the University of Sheffield, Carleton University, and the University of Athabasca; and the DIVA Award for Outstanding Contributions to Women’s Health and Well-Being.

Marcel Saulnier

Associate Assistant Deputy Minister
Strategic Policy Branch
Health Canada
Marcel Saulnier is the Associate Assistant Deputy Minister of the Strategic Policy Branch at Health Canada. He has held other senior positions at Health Canada, including as Director General of Health Care Strategies, and Director General of Policy Coordination and Planning. He played a key role in supporting the work of the federal Advisory Panel on Healthcare Innovation which released its report in June 2015. Marcel’s career has included policy leadership positions at the Canadian Medical Association, the Prime Minister’s Office, Finance Canada, the National Forum on Health, and Health and Welfare Canada. He is currently a member of the Board of Directors of the Canadian Patient Safety Institute and sits on the National Steering Committee for Canada’s Strategy on Patient-Oriented Research. Marcel has a master’s degree in Economics from l’Université de Montreal, and a Bachelor’s in Economics from the University of Ottawa.

Sharon Sholzberg-Gray

Former CEO
Canadian Healthcare Association
Sharon Sholzberg-Gray is a lawyer by profession who had a long career as a Chief Executive Officer in the non-profit sector. Over the years, she served as CEO of a number of national health and social sector organizations, with responsibility for the management of their national offices and policy and advocacy activities. Between 1998 and 2008, she was President and CEO of the Canadian Healthcare Association (CHA), and in that capacity she was the spokesperson for the publicly funded health system in our country. Since her retirement from CHA, she has worked as a health policy advisor and served as Vice Chair of Associated Medical Services. She is currently on the Advisory Committee of the Centre for Health Law, Policy and Ethics at the University of Ottawa Law School.
Sharon is a retired member of the Quebec Bar, has science and law degrees from McGill University, a B.A. from Concordia University and a graduate diploma in public law from the University of Ottawa. She remains active in a wide range of community activities and speaks and writes extensively about legal, health and social issues.
Back to top